Fusion Antibodies' IPO

Fusion Antibodies raised a round of funding on December 18, 2017. Investors include Public.

Fusion Antibodies uses technology to rapidly produce fusion proteins from genes and uses these products as antigens for the production and purification of antibodies.…

Articles about Fusion Antibodies' IPO: